Table 1.
Demographic and Clinical Characteristics of Genetically Screened Patients With Gastroesophageal Cancer
| Characteristic | Patients (N = 489) |
|
|---|---|---|
| No. | % | |
| Age, years | ||
| Median | 64 | |
| Range | 22-96 | |
| Sex | ||
| Male | 367 | 75 |
| Female | 122 | 25 |
| Pathology | ||
| Adenocarcinoma | 460 | 94 |
| Intestinal | 370 | 76 |
| Diffuse | 79 | 16 |
| Mixed | 4 | 0.8 |
| Mucinous | 5 | 1 |
| Medullary | 2 | 0.4 |
| Adenosquamous | 1 | 0.2 |
| Squamous | 21 | 4.3 |
| Neuroendocrine | 7 | 1.4 |
| Differentiation | ||
| Well | 26 | 5 |
| Moderate | 210 | 43 |
| Poor | 248 | 51 |
| Undifferentiated | 5 | 1 |
| Stage* | ||
| 0 | 36 | 7 |
| I | 69 | 14 |
| II | 85 | 17 |
| III | 121 | 25 |
| IV | 178 | 37 |
*
Substaging for esophageal (American Joint Committee on Cancer 2010: esophageal + junctional) and gastric lesions is provided in Fig 2; findings by anatomic location (esophageal v junctional v gastric) are tallied in the Data Supplement.